Search inquiry: <.>II=ЕУ12/2019/41/4<.> |
Total number of found documents : 16
Shown documents from 1 till 16 |
>1.
| Zelinskaya A. Immunocytochemical characteristics of thyrocytes in radioiodine refractory metastases of papillary thyroid cancer/A. Zelinskaya // Experimental Oncology. -К., 2019. т.Том 41,N N 4.-С.342-345
|
>2.
| To the 120th birthday anniversary of academician R. E. Kavetsky // Experimental Oncology. -К., 2019. т.Том 41,N N 4.-С.368-369
|
>3.
| Shkatula P. M. International scientific conference "Tumor and Host: novel aspects of old problem"/P. M. Shkatula // Experimental Oncology. -К., 2019. т.Том 41,N N 4.-С.366-367
|
>4.
| Prylutskyi M. P. Detection of polyamines using immunobiosensor based on zinc oxide nanoparticles/M. P. Prylutskyi, M. F. Starodub // Experimental Oncology. -К., 2019. т.Том 41,N N 4.-С.363-365
|
>5.
| Proteomics of transforming growth factor β1 (TGF β1) signaling in 184A1 human breast epithelial cells suggests the involvement of casein kinase 2α in TGF β1-dependent p53 phosphorylation at Ser392/H. Woksepp [et al.] // Experimental Oncology. -К., 2019. т.Том 41,N N 4.-С.304-311
|
>6.
| Nоn-linear dynamics theory and malignant melanoma/V. E. Orel [et al.] // Experimental Oncology. -К., 2019. т.Том 41,N N 4.-С.291-299
|
>7.
| Molecular mechanisms of oxidation damage and liver cell dysfunction in patients with metastatic colorectal cancer/A. P. Burlaka [et al.] // Experimental Oncology. -К., 2019. т.Том 41,N N 4.-С.328-334
|
>8.
| Moazeni-Roodi A. Association bewtween XPO5 rs 1 1077 polymorphism and cancer susceptibility: a meta-analysis of 7284 cases and 85 1 1 controls/A. Moazeni-Roodi, M. Taheri, M. Hashemi // Experimental Oncology. -К., 2019. т.Том 41,N N 4.-С.346-352
|
>9.
| Karaman O. M. Macrophages - a perspective target for antineoplastic immunotherapy/O. M. Karaman, A. V. Ivanchenko, V. F. Chekhun // Experimental Oncology. -К., 2019. т.Том 41,N N 4.-С.282-290
|
>10.
| How to improve quality of life in patients with acute leukemia and comorbid ischemic heart disease treated with anthracycline-based induction chemotherapy/I. Skrypnyk [et al.] // Experimental Oncology. -К., 2019. т.Том 41,N N 4.-С.353-356
|
>11.
| Fut3 expression in human breast cancer cells under hypoxia and serum deprivation/A. P. B. Albuquerque [et al.] // Experimental Oncology. -К., 2019. т.Том 41,N N 4.-С.318-322
|
>12.
| Deletions in metastatic colorectal cancer with chromothripsis/E. Skuja [et al.] // Experimental Oncology. -К., 2019. т.Том 41,N N 4.-С.323-327
|
>13.
| Cytomegaloviruses and malignant brain tumors/N. I. Lisyany [et al.] // Experimental Oncology. -К., 2019. т.Том 41,N N 4.-С.300-303
|
>14.
| Buchynska L. G. Morphological characteristics and expression of adhesion markers in cells of low differentiated endometrial carcinoma/L. G. Buchynska, L. A. Naleskina, I. P. Nesina // Experimental Oncology. -К., 2019. т.Том 41,N N 4.-С.335-341
|
>15.
| Association of elevated vitamin B12 with oncohematological diseases in a cohort of 79, 524 patients from Lanvia/D. Gavars [et al.] // Experimental Oncology. -К., 2019. т.Том 41,N N 4.-С.357-362
|
>16.
| Apoptosis-inducing effect of spiroaminopyrimidine analogue in NB 4 leukemia cells via down-regulation of BIRC 5 expression/Nayeri M. J. Dehghan [et al.] // Experimental Oncology. -К., 2019. т.Том 41,N N 4.-С.312-317
|
|